Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)
South Korea
· Delayed Price · Currency is KRW 6,450.00
+40.00 (0.62%)
At close: Apr 29, 2026
Seoulin Bioscience Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 56,580 | 57,463 | 61,462 | 78,767 | 97,546 | 174,747 | Upgrade
|
| Market Cap Growth | -3.77% | -6.51% | -21.97% | -19.25% | -44.18% | 62.58% | Upgrade
|
| Enterprise Value | 35,284 | 37,707 | 39,202 | 46,863 | 48,995 | 136,075 | Upgrade
|
| Last Close Price | 6410.00 | 6510.00 | 6845.95 | 8533.50 | 10440.22 | 18480.13 | Upgrade
|
| PE Ratio | 116.55 | 78.50 | 21.09 | - | 9.60 | 11.21 | Upgrade
|
| PS Ratio | 0.73 | 0.75 | 0.82 | 0.88 | 0.93 | 2.17 | Upgrade
|
| PB Ratio | 0.66 | 0.67 | 0.71 | 0.92 | 1.10 | 2.28 | Upgrade
|
| P/TBV Ratio | 0.67 | 0.69 | 0.74 | 0.96 | 1.17 | 2.36 | Upgrade
|
| P/FCF Ratio | 12.96 | 13.16 | - | - | - | 21.89 | Upgrade
|
| P/OCF Ratio | 11.89 | 12.07 | - | 84.64 | - | 19.60 | Upgrade
|
| EV/Sales Ratio | 0.46 | 0.49 | 0.52 | 0.52 | 0.47 | 1.69 | Upgrade
|
| EV/EBITDA Ratio | 18.95 | 20.33 | 16.92 | 12.39 | 4.80 | 14.51 | Upgrade
|
| EV/EBIT Ratio | 50.47 | 54.52 | 41.15 | 18.79 | 5.33 | 18.26 | Upgrade
|
| EV/FCF Ratio | 8.08 | 8.64 | - | - | - | 17.04 | Upgrade
|
| Debt / Equity Ratio | 0.14 | 0.14 | 0.04 | 0.08 | 0.20 | 0.21 | Upgrade
|
| Debt / EBITDA Ratio | 6.24 | 6.24 | 1.59 | 1.78 | 1.74 | 1.68 | Upgrade
|
| Debt / FCF Ratio | 2.65 | 2.65 | - | - | - | 1.97 | Upgrade
|
| Net Debt / Equity Ratio | -0.27 | -0.27 | -0.23 | -0.34 | -0.42 | -0.78 | Upgrade
|
| Net Debt / EBITDA Ratio | -12.47 | -12.47 | -8.56 | -7.59 | -3.67 | -6.35 | Upgrade
|
| Net Debt / FCF Ratio | -5.30 | -5.30 | 4.26 | 1920.12 | 7.78 | -7.46 | Upgrade
|
| Asset Turnover | 0.70 | 0.70 | 0.70 | 0.72 | 0.77 | 0.75 | Upgrade
|
| Inventory Turnover | 2.35 | 2.35 | 2.35 | 3.57 | 5.15 | 4.63 | Upgrade
|
| Quick Ratio | 1.37 | 1.37 | 2.30 | 1.77 | 1.35 | 1.44 | Upgrade
|
| Current Ratio | 2.28 | 2.28 | 4.39 | 2.60 | 1.88 | 1.77 | Upgrade
|
| Return on Equity (ROE) | 0.66% | 0.66% | 3.65% | -2.67% | 12.78% | 23.03% | Upgrade
|
| Return on Assets (ROA) | 0.39% | 0.39% | 0.55% | 1.25% | 4.23% | 4.34% | Upgrade
|
| Return on Invested Capital (ROIC) | 0.70% | 0.69% | 1.36% | 4.63% | 20.31% | 19.66% | Upgrade
|
| Return on Capital Employed (ROCE) | 0.80% | 0.80% | 1.10% | 2.90% | 10.30% | 9.70% | Upgrade
|
| Earnings Yield | 1.29% | 1.27% | 4.74% | -0.15% | 10.41% | 8.92% | Upgrade
|
| FCF Yield | 7.72% | 7.60% | -7.58% | -0.02% | -4.94% | 4.57% | Upgrade
|
| Payout Ratio | 115.25% | 115.25% | 28.70% | - | 7.86% | 4.93% | Upgrade
|
| Buyback Yield / Dilution | -53.00% | -53.00% | 2.96% | 19.46% | -23.72% | 0.07% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.